We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$16.9B
AUM Growth
+$10.5B
Cap. Flow
+$12.3B
Cap. Flow %
72.41%
Top 10 Hldgs %
24.17%
Holding
648
New
193
Increased
117
Reduced
69
Closed
177

Sector Composition

Rank Sector Weight
1 Healthcare 3.81%
2 Communication Services 3.67%
3 Financials 3.11%
4 Technology 3.1%
5 Consumer Discretionary 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRTX icon
401
Heron Therapeutics
HRTX
$63.4M
$482K ﹤0.01%
+114,321
New +$447K
AMTI
402
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$469K ﹤0.01%
481,600
PRAX icon
403
Praxis Precision Medicines
PRAX
$10.2B
$450K ﹤0.01%
13,207
-19,238
-59% -$959K
ICE icon
404
Intercontinental Exchange
ICE
$84.5B
$437K ﹤0.01%
+4,833
New +$485K
FERG icon
405
Ferguson
FERG
$51.2B
$422K ﹤0.01%
+4,100
New +$478K
XLO icon
406
Xilio Therapeutics
XLO
$60.5M
$416K ﹤0.01%
10,207
MPC icon
407
Marathon Petroleum
MPC
$90B
$413K ﹤0.01%
+4,161
New +$390K
PANW icon
408
Palo Alto Networks
PANW
$314B
$393K ﹤0.01%
4,800
-25,002
-84% -$2.17M
LOW icon
409
Lowe's Companies
LOW
$123B
$376K ﹤0.01%
2,001
-847,741
-100% -$165M
ATVI
410
DELISTED
Activision Blizzard
ATVI
$366K ﹤0.01%
+4,927
New +$386K
TBLA icon
411
Taboola.com
TBLA
$1.12B
$362K ﹤0.01%
200,000
DMRA
412
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.82B
$360K ﹤0.01%
7,626
SMTI icon
413
Sanara MedTech
SMTI
$315M
$350K ﹤0.01%
11,805
CVS icon
414
CVS Health
CVS
$122B
$343K ﹤0.01%
3,600
-7,658
-68% -$758K
CRM icon
415
Salesforce
CRM
$162B
$340K ﹤0.01%
+2,367
New +$401K
PR
416
Permian Resources
PR
$17.8B
$340K ﹤0.01%
+50,000
New +$345K
MXL icon
417
MaxLinear
MXL
$6.21B
$326K ﹤0.01%
+10,000
New +$370K
CI icon
418
Cigna
CI
$73.6B
$325K ﹤0.01%
1,171
-964
-45% -$271K
XLI icon
419
State Street Industrial Select Sector SPDR ETF
XLI
$34.5B
$323K ﹤0.01%
3,900
+400
+11% +$36.8K
APLT
420
DELISTED
Applied Therapeutics
APLT
$322K ﹤0.01%
345,900
DAWN
421
DELISTED
Day One Biopharmaceuticals
DAWN
$285K ﹤0.01%
14,237
-763
-5% -$16.2K
UBX
422
DELISTED
Unity Biotechnology
UBX
$277K ﹤0.01%
+70,000
New +$441K
HPQ icon
423
HP
HPQ
$27.3B
$261K ﹤0.01%
10,481
+2,254
+27% +$69.2K
KRE icon
424
State Street SPDR S&P Regional Banking ETF
KRE
$4.56B
$259K ﹤0.01%
4,400
-3,800
-46% -$238K
COP icon
425
ConocoPhillips
COP
$148B
$256K ﹤0.01%
2,498
+1,303
+109% +$130K

Similar funds

Laurion Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Laurion Capital Management held 648 positions worth $16.9B, up 162% from $6.47B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Laurion Capital Management deployed $12.3B of net new capital in Q3 2022, opening 193 new positions and adding to 117 existing holdings. Its largest new stake was Adobe: 254,770 shares worth $70.1M.

By sector, the portfolio is most concentrated in Healthcare at 3.8% of assets, down from 12% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Lowe's Companies, an estimated $165M trimmed.

  • Laurion Capital Management's largest Q3 2022 buy was Adobe: 254,770 shares worth $70.1M.
  • Laurion Capital Management added most to Alphabet (Google) Class A in Q3 2022, an estimated $215M increase.
  • Laurion Capital Management's biggest Q3 2022 reduction was Lowe's Companies, cutting an estimated $165M.
  • Laurion Capital Management fully exited Warner Bros in Q3 2022, selling an estimated $213M.
  • Laurion Capital Management's ten largest holdings make up 24% of its $16.9B portfolio in Q3 2022.
  • Laurion Capital Management opened 193 new positions and closed 177 in Q3 2022.
  • Laurion Capital Management's portfolio value rose 162% quarter-over-quarter to $16.9B.

Based on Laurion Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.